No Picture
Healthcare

Nova Mentis (OTC: NMLSF) Receives Health Canada Approval for First-Of-Its-Kind Psilocybin Clinical Trial

The human study will evaluate the Company’s proprietary psilocybin drug (NM-1001) in the treatment of Fragile X Syndrome Vancouver, British Columbia–(Newsfile Corp. – December 22, 2022) – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) […]

No Picture
Newsmakers

Nextech AR (OTC: NEXCF) Announces Plans For IPO Spin-Out Of 3D Design Studio Toggle3D, Targeting The $11 Billion CAD Market Shift to 3D-Commerce

Toggle3D is Nextech’s Second Spin-Out Following the Successful Debut of ARway TORONTO, Dec. 14, 2022 — Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) is pleased to announce today that […]

No Picture
Healthcare

Nova Mentis’ (OTC: NMLSF) Psilocybin Preclinical Study Published in International Science Journal

Microdose Treatment Modulates Cognition Vancouver, British Columbia— December 8, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and […]